Skip to main content
. 2020 Feb 7;6(3):181–194. doi: 10.1159/000505661

Fig. 7.

Fig. 7

Erk1/2 phosphorylation is diminished in the kidneys from Tubule-FGFR2−/− mice after cisplatin injection. a Representative micrographs showing the immunohistochemical staining images for p-Erk1/2 at day 1 after cisplatin injection. b Western blot analysis showing the induction of Erk1/2 phosphorylation in the kidneys from Tubule-FGFR2−/− or control littermates at different time points after cisplatin injection. c Graph showing the semiquantitative result for p-Erk1/2. * p < 0.05 vs. control littermates, n = 3–4. d Western blot assay for the p-Bad at day 1 after cisplatin injection. e Graph showing the semiquantitative result for p-Bad in the kidneys from Tubule-FGFR2−/− and control littermates. * p < 0.05 vs. control littermates, n = 4. The number indicates the individual animal.